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Abstract
Introduction and hypothesis Variations in outcome measures and reporting of outcomes in trials on surgery for pelvic organ
prolapse (POP) using synthetic mesh have been evaluated and reported. However, the quality of outcome reporting, methodology
of trials and their publication parameters are important considerations in the process of development of Core Outcome Sets. We
aimed to evaluate these characteristics in randomized controlled trials on surgery for POP using mesh.
Methods Secondary analysis of randomized controlled trials on surgical treatments using synthetic mesh for POP previously
included in a systematic review developing an inventory of reported outcomes and outcome measures. The methodological
quality was investigated with the modified Jadad criteria. Outcome reporting quality was evaluated with the MOMENT criteria.
Publication parameters included publishing journal, impact factor and year of publication.
Results Of the 71 previously reviewed studies published from 2000 to 2017, the mean JADAD score was 3.59 and the mean
MOMENT score was 4.63. Quality of outcomes (MOMENT) was related to methodological quality (JADAD) (rho = 0.662; p =
0.000) and to year of publication (rho = 0.262; p = 0.028).
Conclusions Methodological quality and outcome reporting quality appear correlated. However, publication characteristics do
not have strong associations with the methodological quality of the studies. Evaluation of the quality of outcomes, methodology
and publication characteristics are all an indispensable part of a staged process for the development of Core Outcome and
Outcome Measure Sets.
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The use of synthetic mesh for pelvic organ prolapse (POP) sur-
gical treatment has recently decreased because of concerns
around patient safety. These concerns have been the subject of
extensive debates [1], and synthetic meshes for transvaginal POP
repair were reclassified by the FDA as high-risk devices [1–4]. A
high level of evidence on efficacy and safety through systematic
reviews and meta-analyses is warranted to aid clinicians, policy
makers and women in choices of treatment for pelvic organ
prolapse. However, published data are frequently conflicting pos-
sibly on account of arbitrary outcome selection and reporting.
Current research evidence is of variable quality andmethodology
and hence robust practice recommendations are lacking because
of limitations in research evidence. Studies have reported on
variable outcomes, and comparisons among several trials are
not possible because of this heterogeneity [5].
The process of the development of a Core Outcome Set
(COS) includes in-depth evaluation of the selection of out-
comes reported in primary trials. Trials often use variable
methods, and selection of outcomes varies because of authors’
expertise, research priorities and objectives, ethical issues and
other factors. Frequently, trials on the same treatment inter-
vention have been designed with different methods and study
objectives and have been published in various journals
(subspecialized, specialized, general journals) over the years.
Our previous systematic review developed the inventory of
reported outcomes and outcomes measures as a first step in
the process of developing relevant COS based on established
standards and following well-defined study protocols and
high-quality methods [6]. Our systematic reviews on outcome
reporting in trials evaluating surgical treatments in different
prolapse procedures, incontinence and childbirth trauma [5,
7–12] included assessments of associations between outcome
reporting quality, methodological quality and publication
characteristics.
Evaluation of the quality outcome reporting and its associ-
ations with methodological quality might provide useful evi-
dence in developing a core outcome set for this area of re-
search and possibly provide valuable guidance and directions
for future studies.
The aim of this study was to evaluate methodological qual-
ity and outcome quality in trials on surgical treatment of POP
using synthetic mesh and assess the associations of methodo-
logical quality and outcome quality with publication charac-
teristics of the trials including year of publication and journal
impact factor.
Materials and methods
This review is part of CHORUS (An International Collaboration
for Harmonizing Outcomes, Research and Standards in
Urogynecology and Women’s Health, i-chorus.org). This
study was a secondary analysis of data that were part of a
recently published systematic review [5]. Ethical approval was
not required for this study, as this is a secondary analysis of data
included in a previously published systematic review.
The search strategy was described in the original study in
accordance with PRISMA guidelines. We used the following
keywords and MeSH terms: management, repair, operation
and pelvic organ prolapse in the Cochrane, EMBASE,
Medline and Scopus databases from inception until
September 2017. Randomized controlled trials (RCTs) using
synthetic meshes for any type of pelvic prolapse were includ-
ed (Fig. 1). We excluded retrospective studies, literature re-
views, case reports and non-randomized studies. The studies
selected are listed in Appendix 1.
The methodological quality of the included trials was eval-
uated using the modified Jadad score. This is a 5-point scale
that evaluates randomization, adequate method for randomi-
zation; blinded trial described; adequate method for blinding
and if the trial accounts for the patients selected [13]. The
outcome quality was assessed using the MOMENT criteria
(Management of otitis media with effusion in cleft palate score
system), in a 6-point scale. Areas included in the scoring sys-
tem are stating a primary outcome; explaining if the primary
outcome is defined for reproducible measures; stating a sec-
ondary outcome; reporting if the secondary outcome is de-
fined as for reproducible measures; explaining if the choice
of outcome and if the methods used are designed to improve
appropriately the quality of measures [14]. High-quality stud-
ies were considered those that reached score ≥ 4 based on
these criteria. All assessments were undertaken independently
by two assessors in line with our previous studies and similar
research [7–12]. In cases of disagreement, a third assessor
reviewed the scores and provided additional scores. The final
scores were calculated and reviewed by the senior
investigator.
Year and journal of publication and journal impact factor
(IF) were retrieved and documented according to Thomson
Reuters’ (NY, USA) citation reports for obstetrics and gyne-
cology. Statistical analysis was undertaken using SPSS statis-
tical software (IBM Corp., USA). Association among meth-
odological quality, outcome quality, year of publication and
journal’s impact factor was calculated by non-parametric cor-
relation (Spearman’s correlation). Statistical significance was
defined as p < 0.05.
Results
We reviewed and assessed the 71 RCTs previously included
in our systematic review.
Methodological quality, outcome quality and publication
parameters are presented in Table 1. Year of publication
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ranged from 2000 to 2017 and follow-up interval ranged from
1.5 to 74months. Themean Jadad andMOMENT scores were
3.59 and 4.63. Figure 2 shows the quality of outcome
(MOMENT) distribution for the total score, and Fig. 3 shows
the number of studies scored according to each statement.
Fifty-nine studies (83%) were classified as high-quality out-
come reporting, presenting score 4, 5 or 6.
Primary and secondary outcomes were clearly stated in 69
(97%) and 46 (64%) of the studies. Only 34 studies (47%)
provided a rationale for the choice of outcomes but all of them
showed methods to improve the outcome measurement
described.
A non-parametric correlation revealed that the outcome
reporting quality was positively correlated to the methodolog-
ical quality of the trial (rho = 0.662; p = 0.000) and to the year
of publication (rho = 0.262; p = 0.028). Methodological qual-
ity does not appear to be influenced by year of publication (rho
= 0.092; p = 0.444) or the journal’s impact factor (rho = 0.100;
p = 0.417) (Table 2).
Discussion
In our study,outcome reporting quality ( MOMENT
criteria) demonstrated a positive correlation to methodological
quality (Jadad score) and to year of publication. The quality of
outcome reporting has improved in more recently published
trials. However, methodological quality did not have an asso-
ciation with year of publication or the journal’s impact factor.
Not surprisingly, methodological quality and outcome
reporting quality appear correlated possibly because of the
overall study design process and the overall quality of a re-
search protocol. However, such “grading” of the overall qual-
ity of a study does not necessarily translate into a publication
in a journal with a higher impact factor. This observation
highlights the need for harmonization of the quality of meth-
odology and of the reported outcomes and possibly the devel-
opment of set criteria in research protocols that may assist
journal editors in the peer review publication process.
The methodological quality and quality of reported out-
comes as well as publication characteristics should be taken
into consideration during the process of development of core
outcome sets.
One of the strengths of our systematic review is to be the
first one to our knowledge evaluating the methodological
quality as well as outcome reporting quality in trials using
mesh for the treatment of pelvic organ prolapse. We followed
a well-established methodology in a standardized manner in
order to provide unbiased and objective evaluation of the
above-mentioned parameters of the published trials. Another
strength of our study was the independent assessments that
were undertaken and the process of review and consensus
around the final scores of the different domains and items.
However, a number of limitations warrant caution in the
interpretation of our results.
Fig. 1 Randomized controlled
trials (RCTs) using synthetic
meshes for any type of pelvic
prolapse were included
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Table 1 Quality of studies
Author Year Journal IFa Jadad MOMENT
Altman et al. 2011 New England Journal of Medicine 29.1 4 5
Anger et al. 2014 Obstetrics and Gynecology 4.76 2 5
Barber et al. 2009 Obstetrics and Gynecology 4.69 3 4
Bradley et al. 2007 American Journal of Obstetrics and Gynecology 4.45 3 4
Bradley et al. 2008 American Journal of Obstetrics and Gynecology 4.45 3 4
Carey et al. 2009 BJOG: An International Journal of Obstetrics and Gynecology 4.64 3 5
Chmielewski et al. 2011 American Journal of Obstetrics and Gynecology 5.34 4 4
Choe et al. 2000 Journal of Urology 2.64 2 3
Constantini et al. 2016 Journal of Urology 4.68 5 6
Constantini et al. 2007 European Urology 5.96 3 3
Coolen et al. 2017 International Urogynecology Journal 2.078 3 6
Culligan et al. 2005 Obstetrics and Gynecology 4 5 6
Culligan et al. 2013 Obstetrics and Gynecology 4.78 5 6
Cundiff et al. 2008 American Journal of Obstetrics and Gynecology 4.98 3 4
de Tayrac et al. 2013 International Urogynecology Journal 2.53 3 5
Delroy et al. 2013 International Urogynecology Journal 2.45 5 6
Dias et al. 2016 Neurourology and Urodynamics 2.48 5 6
Ek et al. 2013 International Urogynecology Journal 2.53 2 4
Ek et al. 2010 Neurourology and Urodynamics 3.01 5 4
El-Nazer et al. 2012 American Journal of Obstetrics and Gynecology 1.56 5 5
Farthmann et al. 2013 International Urogynecology Journal 2.45 3 3
Freeman et al. 2013 International Urogynecology Journal 2.53 5 6
Glazener et al. 2016 Trials N/A 4 6
Glazener et al. 2017 Health Technology Assessment N/A 4 6
Gupta et al. 2014 South African Journal of Obstetrics & Gynecology 0.23 3 4
Halaska et al. 2012 American Journal of Obstetrics and Gynecology 5.32 3 5
Heinonen et al. 2011 European Journal of Obstetrics & Gynecology and Reproductive Biology 2.58 3 5
Hiltunen et al. 2007 Obstetrics and Gynecology 4.45 3 4
Iglesia et al. 2010 Obstetrics and Gynecology 4.98 5 6
Lakeman et al. 2011 Journal of Sexual Medicine 3.67 3 4
Lamblin et al. 2014 International Urogynecology Journal 2.45 3 5
Lopes et al. 2010 International Urogynecology Journal 2.66 3 3
Madhuvrata et al. 2011 Journal of Obstetrics and Gynecology 0.75 5 5
Maher et al. 2003 American Journal of Obstetrics and Gynecology 3.59 3 5
Maher et al. 2012 American Journal of Obstetrics and Gynecology 5.32 5 6
Maher et al. 2011 American Journal of Obstetrics and Gynecology 5.34 5 6
Menefee et al. 2011 Obstetrics and Gynecology 5.34 5 6
Milani et al. 2011 Journal of Sexual Medicine 3.67 3 6
Natale et al. 2009 International Urogynecology Journal 2.84 3 5
Nieminen et al. 2010 American Journal of Obstetrics and Gynecology 4.98 3 4
Nieminen et al. 2008 International Urogynecology Journal 2.51 3 2
Noé et al. 2013 Archives of Gynecology and Obstetrics 1.63 3 2
Noé et al. 2015 Journal of Endourology 2.09 3 4
Nygaard et al. 2008 American Journal of Obstetrics and Gynecology 4.7 2 4
Nygaard et al. 2013 JAMA - Journal of the American Medical Association 13.59 3 4
Paraiso et al. 2011 Obstetrics and Gynecology 5.34 5 6
Park et al. 2013 International Urogynecology Journal 2.45 3 5
Qatawneh et al. 2013 Gynecological Surgery 0.46 3 5
Rahmanou et al. 2015 International Urogynecology Journal 1.83 3 5
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We evaluated a highly selective cohort of studies leaving
out studies that were non-randomized and with different meth-
odologies. Nevertheless, inclusion of a wider variety of stud-
ies would be likely to demonstrate wider variations and accen-
tuate our findings. Furthermore, our findings are based on the
instruments used and their inherent limitations. Some studies
with higher quality protocols but with suboptimal descriptions
of these protocol in the published text may have received
lower scores than deserved.
Finally, on reviewing the correlation of the quality of the
trial and the journal impact factor, we should take into consid-
eration that the choice of the journal a study was published in
Table 1 (continued)
Author Year Journal IFa Jadad MOMENT
Rane et al. 2004 Australian and New Zealand Journal of Obstetrics and Gynecology 0.87 5 5
Rondini et al. 2015 International Urogynecology Journal 2.17 3 4
Roovers et al. 2005 Neurourology and Urodynamics 3.23 3 5
Roovers et al. 2004 BJOG: An International Journal of Obstetrics and Gynecology 3.01 3 5
Rudnicki et al. 2015 BJOG: An International Journal of Obstetrics and Gynecology 2.9 3 3
Rudnicki et al. 2014 BJOG: An International Journal of Obstetrics and Gynecology 2.9 3 5
Sand et al. 2001 American Journal of Obstetrics and Gynecology 2.72 3 4
Silveira et al. 2014 International Urogynecology Journal 2.17 3 5
Shi et al. 2017 Medical Science Monitor N/A 2 3
Sivaslioglu et al. 2008 International Urogynecology Journal 2.79 3 2
Svabik et al. 2014 Ultrasound in Obstetrics and Gynecology 4.5 4 5
Tamanini et al. 2015 Journal of Urology 4.68 4 5
Tamanini et al. 2013 International Braz J Urol: official journal of the Brazilian Society of Urology 1.24 4 5
Tamanini et al. 2013 International Braz J Urol: official journal of the Brazilian Society of Urology 1.24 4 5
Tan-Kim et al. 2014 International Urogynecology Journal 2.17 5 6
Turgal et al. 2013 European Journal of Obstetrics & Gynecology and Reproductive Biology 2.4 3 2
Visco et al. 2008 International Urogynecology Journal and Pelvic Floor Dysfunct. 2.51 5 4
Vollebregt et al. 2012 Journal of Sexual Medicine 3.67 5 6
Vollebregt et al. 2011 BJOG: An International Journal of Obstetrics and Gynecology 2.96 5 6
Weber et al. 2001 American Journal of Obstetrics and Gynecology 2.72 2 3
Withagen et al. 2011 Obstetrics and Gynecology 5.34 5 6
Yuk et al. 2012 Journal of Minimally Invasive Gynecology 2.1 3 3
a Journal’s impact factor
Fig. 2 Distribution of scores on
quality of outcome reporting
(MOMENT scores)
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can be influenced by many factors not necessarily associated
directly with the quality of the study. For example, a presen-
tation of a study at a conference may be rewarded by an offer
of a fast track review of the paper in the journal associated to
the society organizing the conference. Some authors may also
select a journal to submit based on personal preference, influ-
enced by factors such as journal loyalty of the author, previous
or current association with the journal’s editorial board or
other factors. Hence, this correlation between quality of a trial
and journal of publication should always be interpreted with
caution for such biases that cannot be weighed.
In the studies included in this evaluation, methodological
quality of trials was positively associated with outcome qual-
ity but was not strongly associated to year of publication and
the journal’s impact factor. The instruments and methodology
described, already widely used in many fields of medical re-
search, in gynecology, obstetrics and urogynecology, were
applied to analyze in a standardized way important parameters
of published research [5]. This assessment is in our opinion a
fundamental prerequisite in the process of developing a high
quality COS in line with the standards established by the
COMET, COSMIN and CROWN initiatives.
Nevertheless, we believe that this study may also provide
invaluable guidance for improving better selection of out-
comes and measurement tools, outcome reporting, research
methods and publication strategies for future research in this
area. Harmonized methodology and outcome selection and
reporting may improve the comparability of primary research,
which in turn may inform robust meta-analyses and eventually
improve clinical practice.
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Fig. 3 Number of studies
satisfying the specific statements
(yes or no) on quality of
outcomes’ assessment
Table 2 – Univariate correlation on publication characteristics, JADAD score and MOMENT score
MOMENT score JADAD IFb
Spearman’s Rho p N Spearman’s Rho p N Spearman’s Rho p N
Yeara 0,262 0,028 71 0,920 0,444 71 –0,320 0,008 68
IFb 0,162 0,187 68 0,100 0,417 68 – – –
JADAD 0,662 0,000 71 – – – – – –
a Year of publication
b Journal’s impact factor
N number
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